Prudent to have omicron vaccine, but may not be needed: Fauci
>> Reuters
Published: 25 Jan 2022 11:21 PM BdST Updated: 25 Jan 2022 11:21 PM BdST
-
Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, answers questions during a Senate Health, Education, Labour, and Pensions Committee hearing to examine the federal response to the coronavirus disease (COVID-19) and new emerging variants at Capitol Hill in Washington, DC, US Jan 11, 2022. Greg Nash/ REUTERS
A COVID-19 vaccine specifically targeting the omicron variant would be "prudent" even if it ultimately may not be needed, the top US infectious disease official said on Tuesday as Pfizer announced trials for such a vaccine.
"It makes sense to think in terms of at least having ready an omicron specific boost," Dr Anthony Fauci, President Joe Biden's top medical adviser and a member of the White House COVID-19 Response Team, told MSNBC.
"We may not need it... but I think it's prudent to at least prepare for the possibility that this may be a persistent variant that we may have to face - even if it's at a very low level," he added.
Earlier on Tuesday, Pfizer Inc and its partner BioNTech SE said they have started clinical trials for a version of their vaccine targeting the highly-transmissible variant that has eluded their current two-dose protection and led to breakthrough infections.
While much of the nation is still grappling with high omicron infections even as cases subside in some states, Fauci said eventually enough community immunity will hopefully build-up to prevent massive surges such as the four to five waves driven by variants so far.
"I don't think we're going to be seeing that indefinitely," he said, adding that COVID was unlikely to be eradicated.
-
Ireland logs first monkeypox case
-
Disease experts call for action on monkeypox
-
Monkeypox can be contained if we act now: WHO
-
Cancer treatments may benefit from pandemic lessons
-
Spain's monkeypox case tally rises to 84
-
Africa CDC warns on monkeypox vaccine hoarding
-
Bacteria with antibiotic resistant genes discovered in Antarctica
-
What vaccines do we have to combat monkeypox?
-
Pfizer's Paxlovid use spikes, doctors reconsider its value for COVID treatment
-
23 unauthorised clinics, diagnostic centres sealed off in four districts
-
First case of monkeypox confirmed in Ireland
-
Disease experts call on WHO, governments for more action on monkeypox
-
Monkeypox can be contained if we act now: WHO
-
Cancer treatments may benefit from lessons of pandemic set-backs
Most Read
- 2 Bangladeshi policemen reported ‘missing’ in Netherlands after training
- Bangladeshi faces deportation, separation from family after 25 years in Canada
- Mashiur says donors offered him foreign consultancy if he gave up Padma Bridge job
- Russia pummels eastern towns in bid to encircle Ukraine forces
- Bangladesh to set uniform dollar exchange rate amid currency volatility
- Bangladesh bids farewell to Abdul Gaffar Chowdhury, who penned immortal Language Movement song
- Clinical Real Madrid beat Liverpool to claim 14th Champions League title
- Sri Lanka to pay $72.6m for 90,000 tonnes Russian oil, minister says
- Is Bangladesh's current $42bn forex reserve safe enough?
- Bus crashes into a tree in Barishal, 9 dead